SCHEMBL2079062

SCHEMBL2079062

Nc1c[nH]ccc1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6604173 0.68
SCHEMBL2239840 0.68
SCHEMBL9195922 0.67 ALDH1A1 (0.67)
SCHEMBL4442463 0.67
SCHEMBL9350775 0.67
SCHEMBL534932 0.65
SCHEMBL19429583 0.65
SCHEMBL14231153 0.65
SCHEMBL3595886 0.64 ALDH1A1 (0.42)
SCHEMBL830377 0.64 ALDH1A1 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180222869-A1 ANTICANCER DRUGS INCLUDING THE CHEMICAL STRUCTURES OF AN ANDROGEN RECEPTOR LIGAND AND A HISTONE DEACETYLASE INHIBITOR UNITED STATES GOVERNMENT 2018-08-09 US disclosed
CN-108368081-A Andrographolide changes structure compound 黑龙江珍宝岛药业股份有限公司 2018-08-03 CN disclosed
US-9963433-B2 Anticancer drugs including the chemical structures of an androgen receptor ligand and a histone deacetylase inhibitor WAYNE STATE UNIVERSITY (US) 2018-05-08 US disclosed
US-20170217903-A1 ANTICANCER DRUGS INCLUDING THE CHEMICAL STRUCTURES OF AN ANDROGEN RECEPTOR LIGAND AND A HISTONE DEACETYLASE INHIBITOR WAYNE STATE UNIVERSITY 2017-08-03 US disclosed
CN-106800551-A Andrographolide changes structure compound 南京明德新药研发股份有限公司 2017-06-06 CN disclosed
US-7906530-B2 1,7-naphthyridine derivatives as p38 MAP kinase inhibitors LABORATORIOS ALMIRALL, S.A. (ES) 2011-03-15 US disclosed
US-20100227881-A1 1,7-NAPHTHYRIDINE DERIVATIVES AS P38 MAP KINASE INHIBITORS LABORATORIOS ALMIRALL, S.A. (ES) 2010-09-09 US disclosed
EP-2049537-A1 1, 7-NAPHTHYRIDINE DERIVATIVES AS P38 MAP KINASE INHIBITORS Laboratorios Almirall, S.A. (ES) 2009-04-22 EP disclosed
CN-101277965-A Imidazo [2, 1-b ] thiazole derivatives as SIRTUIN modulating compounds SIRTRIS PHARMACEUTICALS INC (US) 2008-10-01 CN disclosed
WO-2008017461-A1 1, 7-NAPHTHYRIDINE DERIVATIVES AS P38 MAP KINASE INHIBITORS LABORATORIOS ALMIRALL, S.A. (ES) 2008-02-14 WO disclosed
CN-1161344-C 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof and process for preparation of both ������ҩ��ʽ���� 2004-08-11 CN disclosed
EP-1020453-B1 6,7-ASYMMETRICALLY DISUBSTITUTED QUINOXALINECARBOXYLIC ACID DERIVATIVES, ADDITION SALTS THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN SEIYAKU KK (JP) 2004-05-19 EP disclosed
US-6348461-B1 CENTRAL NERVOUS SYSTEM ANTAGONIST WITH HETEROCYCLIC SUBSTITUENTS KYORIN PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
CN-1269794-A 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof and process for preparation of both KYORIN SEIYAKU KK (JP) 2000-10-11 CN disclosed
EP-1020453-A1 6,7-ASYMMETRICALLY DISUBSTITUTED QUINOXALINECARBOXYLIC ACID DERI VATIVES, ADDITION SALTS THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 EP disclosed
EP-0489327-B1 Chroman derivatives MERCK PATENT GMBH (DE) 1998-05-27 EP disclosed
US-5238937-A PYRIDAZINY OR OXODIHYDROPYRIDAZINYL CHROMAN DERIVATIVES MERCK PATENT GESELLSCHAFT (DE) 1993-08-24 US disclosed
EP-0489327-A1 Chroman derivatives MERCK PATENT GmbH (DE) 1992-06-10 EP disclosed
US-4131677-A Anti-inflammatory oxazolo [5,4-b]pyridines MERCK & CO., INC. (US) 1978-12-26 US disclosed
US-4038396-A ANTIPYRETICS, ANALGESICS MERCK & CO., INC. (US) 1977-07-26 US disclosed